Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Phillips

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Transplantation|August 1, 1981
Biochemical characterization of Syrian hamster cell surface alloantigens. III. Hamster alloantisera immunoprecipitate class II-like, but not class I-like, moleculesJ W Streilein, J T Phillips, J Stein-Streilein, et al.
Monographs in Allergy|January 1, 1988
Ciclosporin in the treatment of myasthenia gravisR S Tindall, J T Phillips, J A Rollins, et al.
The New England Journal of Medicine|March 19, 1987
Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravisR S Tindall, J A Rollins, J T Phillips, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and managementE M Frohman, K Brannon, Sherry Alexander, et al.
Oncogene|March 21, 2006
Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancerA Leiblich, S S Cross, J W F Catto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2010
Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patientsR A Rudick, L Kappos, R Kinkel, et al.
European Journal of Neurology|January 6, 2015
Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosisL Kappos, G Giovannoni, R Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2004
An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosisT L Vollmer, J T Phillips, A D Goodman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 26, 2002
Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z scoreE M Frohman, T C Frohman, P O'Suilleabhain, et al.
Injury|January 29, 2011
Assessment of hepatic inflammation after spinal cord injury using intravital microscopyH Hundt, J C Fleming, J T Phillips, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Transplantation|August 1, 1981
Biochemical characterization of Syrian hamster cell surface alloantigens. III. Hamster alloantisera immunoprecipitate class II-like, but not class I-like, moleculesJ W Streilein, J T Phillips, J Stein-Streilein, et al.
Monographs in Allergy|January 1, 1988
Ciclosporin in the treatment of myasthenia gravisR S Tindall, J T Phillips, J A Rollins, et al.
The New England Journal of Medicine|March 19, 1987
Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravisR S Tindall, J A Rollins, J T Phillips, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and managementE M Frohman, K Brannon, Sherry Alexander, et al.
Oncogene|March 21, 2006
Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancerA Leiblich, S S Cross, J W F Catto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2010
Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patientsR A Rudick, L Kappos, R Kinkel, et al.
European Journal of Neurology|January 6, 2015
Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosisL Kappos, G Giovannoni, R Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2004
An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosisT L Vollmer, J T Phillips, A D Goodman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 26, 2002
Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z scoreE M Frohman, T C Frohman, P O'Suilleabhain, et al.
Injury|January 29, 2011
Assessment of hepatic inflammation after spinal cord injury using intravital microscopyH Hundt, J C Fleming, J T Phillips, et al.
Pageof 3